Loading...
Market
Geographic focus of Transcarent's acquisitions in 2024
5
Resolution / Starting Odds
North America • 34%
Europe • 33%
Asia-Pacific • 33%
Company press releases, SEC filings, or major news outlets
Story
Transcarent Raises $126M, Valued at $2.2B, Eyes AI Expansion and Acquisitions
May 2, 2024, 03:30 PM
Transcarent, a health tech unicorn co-founded by Glen Tullman, has successfully raised $126 million in a Series D funding round. The round was led by General Catalyst and 7wireVentures. This new influx of capital, which values Transcarent at $2.2 billion, is earmarked for advancing AI projects and strategic acquisitions. The funding signifies a positive shift in the health tech funding landscape, suggesting a market rebound.
View original story
Similar markets
North America • 25%
Europe • 25%
Both North America and Europe • 25%
Neither • 25%
Remains in current markets • 25%
Expands to Europe • 25%
Expands to Asia • 25%
Expands globally • 25%
North America • 20%
Europe • 20%
Asia • 20%
South America • 20%
Australia • 20%
Tech services company • 33%
Software development company • 33%
Other • 34%
Tech Company • 33%
Healthcare Company • 33%
Other Sector • 33%
North America • 25%
Europe • 25%
Asia • 25%
Other regions • 25%
Only in the US • 33%
US and one other country • 33%
US and multiple countries • 34%
Remains in current markets • 25%
Expands to Europe • 25%
Expands to Asia • 25%
Expands globally • 25%
Europe • 25%
Asia • 25%
North America • 25%
No expansion • 25%
Expands to Europe • 25%
Expands to Asia • 25%
Expands to Latin America • 25%
No expansion • 25%
Asia-Pacific • 25%
Europe • 25%
North America • 25%
Middle East • 25%